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Abstract
The Agricultural Research Center of the United States Department of Agriculture 
identifies bovine respiratory disease (BRD) as the most common and costly disease of 
feedlot cattle in the United States (1). The alveolar macrophage serves as the first line of 
defense for the lung alveolus by recognition, phagocytosis, and destruction of the 
bacterial agents reaching the alveolus. 
CD163 is a monocyte/macrophage-restricted, cysteine-rich, scavenger receptor 
that binds and internalizes circulating haptoglobin-hemoglobin (Hp–Hb) complexes (5). 
Macrophages expressing high levels of CD163 appear to be present in the resolution 
phase of inflammation (7). 
The purpose of this study was to further our understanding of the cellular 
regulation of host inflammatory mediators in bovine respiratory diseases by determining 
the expression of CD163 on alveolar macrophages and peripheral blood mononuclear 
derived macrophages. 
Bovine peripheral blood mononuclear cells (PBMC) were isolated from the whole 
blood of healthy calves and cultured for differentiation into macrophages. After cellular 
differentiation, the cultured cells and freshly isolated alveolar macrophage cells obtained 
by bronchoalveolar lavage were labeled with anti-CD163 antibodies and evaluated for 
expression of CD163 by flow cytometry. Positive expression of CD163 (61.83%) was 
observed on alveolar macrophages. These findings demonstrate that bovine macrophages 
do express a surface protein similar to CD163. Nevertheless, neither the peripheral blood 
monocytes nor the monocyte-derived macrophages expressed CD163 in any of our trials. 
Four of the six flow cytometry runs also did not reveal a high level of monocyte-
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macrophage differentiation, however, with the modification of our isolation and culturing 
techniques, the final two flow cytometry runs demonstrated higher levels of cellular 
differentiation. 
Additional studies are needed to determine expression of CD163 on macrophages 
derived from peripheral blood mononuclear cells, and alternative methods of 
differentiation will be necessary to reproducibly induce CD163 expression and further the 
understanding of the CD163-associated, anti-inflammatory pathway.
Introduction
The Agricultural Research Center of the United States Department of Agriculture 
identifies bovine respiratory disease (BRD) as the most common and costly disease of
feedlot cattle in the United States (1). More beef cattle develop and subsequently die 
from respiratory diseases than from any other cause, costing over one billion dollars
annually to the cattle industry (2). We now know that bovine respiratory diseases are 
caused by the presence of one or more pathogenic organisms, and the manifestation of 
this clinical disease is caused by a complex interaction of various host, pathogen, and 
environmental factors (3). 
Monocytes and macrophages are prominent cells at sites of chronic inflammation 
(4). The alveolar macrophage specifically serves as the first line of defense against 
bovine respiratory disease by the recognition, phagocytosis, and destruction of bacterial 
agents reaching the alveolus. In the presence of more virulent organisms, the alveolar 
macrophage recruits other inflammatory cells to the lung in order to limit microbial 
infection. 
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CD163 is a monocyte/macrophage-restricted, cysteine rich protein, scavenger 
receptor that binds and internalizes circulating haptoglobin-hemoglobin (Hp–Hb) 
complexes (5). CD163 action on the haptoglobin-hemoglobin complex fuels an anti-
inflammatory response mediated by heme metabolites. Monocytes express CD163 
constitutively at low levels, but expression increases during macrophage differentiation 
(6). Macrophages expressing high levels of CD163 appear to be present in the resolution 
phase of inflammation (7), and are therefore thought to play an important role in bovine 
respiratory disease. CD163 is an attractive candidate for potential diagnostic use as a 
marker of monocyte/macrophage activity because of its apparent roles in the anti-
inflammatory response. Nevertheless, it is unclear how many or what kinds of circulating 
monocytes express the CD163 molecule on their surface (5).
Objective
Identify and determine expression of CD163 in bovine alveolar macrophages and 
macrophages derived from bovine peripheral blood mononuclear cells in order to further 
the understanding of the cellular regulation of host inflammatory mediators in bovine 
respiratory diseases and possibly assist in the treatment and prevention of bovine 
respiratory diseases.
Materials and Methods
Isolation and Incubation of Monocytes for Tissue Cell Culture
Approximately 50 milliters of whole blood were drawn from healthy calves 
available for research at The Ohio State University Veterinary Teaching Hospital. The 
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plasma was removed from the blood and the buffy coat (a layer that includes monocytes 
and leukocytes) was diluted with phosphate buffer solution or Hank’s buffered salt 
solution. Histopaque was used to separate cells and isolate the monocytes for culture. 
After washing the cells with phosphate buffered solution, 10 microliters of cells were 
diluted with 90 microliters of phosphate buffered solution and counted on a 
hemocytometer. Cells were also stained and examined under a microscope for type and 
quality. After being counted on the hemocytomer, monocytes were diluted to 1 x 106
cells/mL and placed into culture wells with a cell media culture made up of RPMI-1640
with 2mM L-glutamine, 1.5% sodium bicarbonate, 4.5 g./L glucose, 10 mM HEPES, 1 
mM sodium pyruvate, and 10% fetal bovine serum to promote differentiation into 
macrophages. Cells were cultured at 37 Celsius in a 5% CO2 incubator for 
approximately eleven days. Twenty-four hours after being initially placed into culture, 
75% of the cell media was removed from the culture and cells were washed with 
phosphate buffered solution before being placed back into culture with new media. This 
process was repeated every three to five days until day eleven.  Cell culture plates were 
also examined under a microscope to monitor any changes in cell size, number, or 
condition. Some cell cultures were treated with a 1/1000 dexamethasone/RPMI cell 
culture media solution to encourage up-regulation of CD163 expression. 
Removal and Labeling of Monocyte-Derived Macrophages with Anti-CD163 Antibodies 
On day eleven, the cells were removed from the culture by pipetting out the old 
media and adding cold phosphate buffered solution to the cell culture wells for ten 
minutes before scraping the cell culture wells with cell scrapers. The remaining cells and 
media were then recounted on the hemocytometer and re-diluted to 1 x 106 cells/mL. One 
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millliter of this solution was added to each flow cytometry tube and centrifuged to form a 
small pellet of cells. The liquid was removed and 100 microliters of phosphate buffered 
solution with 20mM glucose and 1% bovine serum albumin was added to each tube and 
the appropriate volume of Serotec antibodies were added to each tube. Primary antibodies 
used were Serotec Mouse Anti-Porcine. The isotype/negative control antibody was a 
Serotec IgG1 Negative Control, and the secondary antibody used was a Goat Anti-Mouse 
IgG (H & L) (Multi-species absorbed): FITC antibody. The appropriate antibodies were 
added to each tube (2 primary, 1 isotype/negative control, 1 no primary antibody, and 1 
untreated tube) and incubated at room temperature for 30 minutes. After incubation cells 
were again washed with phosphate buffered solution with glucose and bovine serum 
albumin. Secondary antibody was then added to the appropriate tubes and cells were 
cultured again, this time in the dark, at room temperature for 30 minutes. Following a 
final washing in the phosphate buffered solution, cells were resuspended to 500 
microliters with either phosphate buffered solution with glucose and bovine serum 
albumin or 0.5% paraformaldehyde in phosphate buffered solution. Cells placed in the 
paraformaldehyde solution could incubate for up to one week in the 4 Celsius 
refridgerator. Final cell solutions were taken to the ImCore Cytometry Lab at the Center 
for Retrovirus Research in Goss Laboratories of The Ohio State University. Flow 
cytometry was run by a technician, Elizabeth Wheeler, and the resulting data was shared. 
Alveolar macrophage cells were also harvested on two occasions from healthy, 
anesthetized calves by bronchoalveolar lavage conducted by Dr. Jeff Lakritz, DVM of 
The Ohio State University Veterinary Teaching Hospital. These cells were also washed in 
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phosphate buffered solution and labeled with the anti-CD163 antibodies in the same way 
the cultured monocyte-derived macrophages were labeled.
Results
Flow cytometry was run on six groups of cultured, differentiated peripheral blood 
mononuclear cells and bovine alveolar macrophages for a total of forty-three samples. 
Cell samples in four of the six flow cytometry runs did not reveal a high enough level of 
monocyte-macrophage differentiation to identify an absence of the CD163 response. 
After researching alternative monocyte culturing techniques, we were able to obtain a 
higher percentage of differentiated cells. 
Positive expression of CD163 (61.18%) was found on the alveolar macrophage
cells isolated by bronchoalveolar lavage. These findings demonstrate that bovine 
macrophages from the lungs do express a surface protein that is at least similar to CD163.
These findings also confirmed the potential of the anti-CD163 anti-porcine antibodies we 
had chosen.
Nevertheless, neither the undifferentiated peripheral blood monocytes nor the 
monocyte-derived macrophages expressed significant levels of CD163 fluorescence in 
any of our trials.
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 Figure 1 Figure 2
Figure 1 – Undifferentiated bovine peripheral blood mononuclear cells.
Figure 2 – Bovine peripheral blood mononuclear cells that have differentiated 
into macrophages.
Flow Cytometry Data Results
The following data was selected from three of our most representative flow 
cytometry sample results. The data demonstrates, respectively, very little monocyte 
differentiation and no CD163 expression, monocyte differentiation into macrophages 
with insignificant levels of CD163 expression, and alveolar macrophages demonstrating a 
significant level of cellular differentiation and CD163 expression. 
The scatter graph axes and expected cellular location and differentiation are 
defined in Figure #3 and can also be applied to Figure #5 and Figure #7. Figures #4, #6, 
and #8 measure the cellular level of fluorescence on a log scale. The blue peaks 
demonstrate the location(s) of the highest levels of fluorescence. The desired data on 
these graphs would include two peaks, with the largest shifted toward the middle or right 
of the graph area. Insignificant levels are seen in Figures #4 and #6, and Figure #8 
demonstrates more desirable flow cytometry data.
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Scatter Plot
Cultured peripheral blood mononuclear cells demonstrating very little differentiation
from monocytes into macrophages and no CD163 expression.
     
        
               
Cell Complexity
Cell 
Size
Macrophage Location
Monocyte Location
Lymphocyte Location
Figure #3
Region Number %Total %Gated X-Mean
  I           9    0.07     0.07    342.1
R  10,000    82.78    82.78      72.6
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Fluorescence Log Scale
Cultured peripheral blood mononuclear cells demonstrating negligible CD163 
expression by fluorescence.
                      
Figure #4
Region Number %Total %Gated X-Mean
T    120 0.99 1.20 0.7
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Scatter Plot
Cultured peripheral blood mononuclear cells demonstrating a high level of monocyte 
differentiation into macrophages, but insignificant CD163 expression.
        
Figure #5
Region Number %Total          %Gated          X-Mean
I               10,000      9.47  9.47 236.0
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Fluorescence Log Scale
Cultured peripheral blood mononuclear cells demonstrating negligible CD163 
expression.
                       
  
Figure #6
Region Number %Total %Gated         X-Mean
F   217 0.21 2.17 1.7
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Scatter Plot
Alveolar macrophage cells obtained by bronchoalveolar lavage demonstrating a high 
level of cellular differentiation and positive CD163 expression by fluorescence.
       
Figure #7
Region Number %Total %Gated X-Mean
       I    10,000     46.94     46.94     364.7
      R        2571     12.07     12.07            61.0
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Fluorescence Log Scale
Cultured peripheral blood mononuclear cells demonstrating positive CD163 expression 
by fluorescence (61.18% and shifted peak).
                   
Figure #8
Region Number %Total %Gated X-Mean
F  6118 28.72 61.18     5.0
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Implications and Conclusion
Previous studies have shown that Interleukin-10 (IL-10) and glucocorticoids may 
induce higher CD163 expression on cultured monocytes. The fact that CD163 can be up-
regulated by potent anti-inflammatory mediators such as glucocorticoids and IL-10 is a 
strong indicator that CD163 may be an important anti-inflammatory molecule and a 
potential biomarker for inflammation and inflammatory conditions (8). Based on the 
inconclusive results of our study, however, additional studies will be needed to determine 
expression of CD163 on macrophages derived from peripheral blood mononuclear cells. 
Alternative methods of differentiation are suggested in order to reproducibly 
induce CD163 expression and further the understanding of the CD163-associated, anti-
inflammatory pathway. Some possible modifications that may assist in determining the 
expression of CD163 include treating cell cultures with Interleukins (IL-6 or IL-10) to 
encourage up-regulation of the anti-inflammatory response or possibly culturing 
peripheral blood mononuclear cells with the CD163 positive alveolar macrophage cells to 
induce CD163 expression. Another suggested possibility is to use haptoglobin bound to 
hemoglobin in an attempt to induce binding and stimulation of the possible CD163 on 
macrophages. 
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